Medicinova Stock Widgets and Gadgets
| MNOV Stock | USD 2.00 0.05 2.56% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- MNOV MediciNova
- Latest MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
- MNOV 2.0 0.05
- Low 1.92
- High 2.05
- Volume 81.4 K
- Alpha 1.19
- Beta -2.52
- Return On Equity -0.13
- Return On Asset -0.0951
- Operating Margin (9.82) %
- Current Valuation 51.49 M
- Shares Outstanding 49.05 M
- Shares Owned By Insiders 2.98 %
- Shares Owned By Institutions 21.30 %
- Number Of Shares Shorted 182.2 K
- Price To Earning (24.69) X
- Price To Book 1.67 X
- Price To Sales 95.64 X
- Revenue 1000 K
- Gross Profit 4.04 M
- EBITDA (9.88 M)
- Net Income (8.57 M)
- Cash And Equivalents 65.23 M
- Cash Per Share 1.33 X
- Total Debt 215.93 K
- Debt To Equity 0.01 %
- Current Ratio 17.17 X
- Book Value Per Share 1.27 X
- Cash Flow From Operations (7.43 M)
- Short Ratio 11.20 X
- Earnings Per Share (0.16) X
- Price To Earnings To Growth (0.94) X
- Target Price 8.0
- Number Of Employees 13
- Beta 0.77
- Market Capitalization 95.64 M
- Total Asset 66.27 M
- Retained Earnings (415.7 M)
- Working Capital 47.9 M
- Current Asset 22.73 M
- Current Liabilities 1.49 M
- Net Asset 66.27 M
- Accumulation Distribution 5162.14
- Daily Balance Of Power 0.3846
- Rate Of Daily Change 1.03
- Day Median Price 1.99
- Day Typical Price 1.99
- Price Action Indicator 0.04
- Period Momentum Indicator 0.05
- Relative Strength Index 53.0
Market Snapshot Widget Example
DAX Index Germany | 19,146 0.74 | |
Taiwan Weighted Taiwan | 22,556 0.58 | |
PSI 20 Stock Portugal | 6,360 0.12 | |
CROBEX Croatia | 3,125 0.11 | |
Budapest SE Hungary | 79,229 0.17 | |
IDX 30 Jakarta Indonesia | 442.58 1.06 | |
ISEQ 20 Price Ireland | 1,608 0.49 | |
NYSE Comp USA | 19,968 1.11 | |
Tel Aviv 35 Israel | 2,260 0.33 | |
Coreshares Index Tracker South Afric | 1,084 1.63 | |
IPC MEXICO Mexico | 50,170 0.05 | |
KL Technology Malaysia | 59.11 0.3 | |
IBEX 35 Index Spain | 11,612 0.19 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,525 0.64 | |
SPASX Dividend Opportunities Australia | 1,683 0.08 | |
HNX 30 Vietnam | 461.57 1.23 | |
Bucharest BET-NG Romania | 1,208 0.07 | |
AMS Small Cap Netherlands | 1,174 0.29 | |
Oslo Exchange Mutual Norway | 1,416 0.74 | |
BEL Small Belgium | 8,063 0.05 | |
Basic Materials Brazil | 5,689 0.1 | |
Swiss Leader Price Switzerland | 1,912 0.48 | |
Fondo Mutuo ETF Chile | 1,374 0.26 | |
Athens General Comp Greece | 1,398 0.94 | |
Stock Exchange Of Thailand | 1,440 1.51 | |
PX Prague Stock Czech Repub | 1,678 0.63 | |
THE PHILIPPINE STOCK Philippines | 6,863 1.61 | |
WIG 30 Poland | 2,792 1.67 | |
BIST Electricity Turkey | 480.91 2.00 |
Investing Ideas
In addition to having MediciNova in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare MediciNova
Compare MediciNova To Peers
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.